COVID-19

News

US biotech uses AI to pick antiviral for COVID-19 trial

US biotech AI Therapeutics has begun a phase 2 trial of its LAM-002A, an antiviral drug that has shown promise against the SARS-CoV-2 coronavirus in the lab.

News

Moderna gets further $472m as expanded phase 3 COVID-19 tria...

A US government agency is to give a further $472 million to biotech Moderna, after it announced plans to expand a phase 3 trial for its potential COVID-19 jab.

News

Great Britain £50 - fifty pounds sterling notes spead out.

UK pharma resilient in 2Q, despite pandemic fallout

UK manufacturing exports fell sharply during the second quarter as the COVID-19 pandemic gathered pace, but pharma and healthcare products were much less affected, says a

Views & Analysis

Coronavirus pharma news roundup – 24/07/20

With coronavirus vaccine trials finally showing positive results, analysts are starting to wonder what access challenges might lie ahead.

News

Influential MPs 'astonished' at UK government's delayed pand...

As the UK’s economy is hit by its worst contraction for 41 years, an influential committee of MPs has blasted the government’s failure to plan for the economic impact of a pandemic and stoc

News

Pandemic and currency headwinds hurt Roche in first half

Roche has announced half-year results showing the COVID-19 pandemic affected sales of its key products, with currency headwinds also weighing on revenues.

US biotech uses AI to pick antiviral for COVID-19 trial

Moderna gets further $472m as expanded phase 3 COVID-19 tria...

UK pharma resilient in 2Q, despite pandemic fallout

Coronavirus pharma news roundup – 24/07/20

Influential MPs 'astonished' at UK government's delayed pand...

Pandemic and currency headwinds hurt Roche in first half

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

COVID-19

Editor's Picks